- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Southlake Today
By the People, for the People
HeartSciences Inc. Launches Securities Offering
The Texas-based medical device company seeks new funding for expansion.
Apr. 17, 2026 at 11:14pm
Got story updates? Submit your updates here. ›
HeartSciences' new securities offering aims to fund the continued development of its innovative cardiac monitoring technology.Southlake TodayHeartSciences Inc., a medical device company based in Southlake, Texas, has filed a Form 253G2 with the SEC to launch a new securities offering. The company is seeking to raise additional capital through a best efforts offering of up to an unspecified amount, with the proceeds to be used for further expansion and growth initiatives.
Why it matters
As a private company, HeartSciences' securities offering represents an opportunity for accredited investors to potentially gain ownership in a promising medical technology firm. The funds raised could help the company accelerate the development and commercialization of its innovative cardiac monitoring devices.
The details
According to the filing, HeartSciences develops advanced electrocardiography (ECG) technologies for early detection of heart disease. The company plans to use the proceeds from the offering to support ongoing R&D, expand manufacturing capabilities, and increase sales and marketing efforts for its products.
- The securities offering was filed with the SEC on April 17, 2026.
The players
HeartSciences Inc.
A private medical device company based in Southlake, Texas that develops advanced ECG technologies for heart disease detection.
What’s next
The offering is currently open to accredited investors, with the company seeking to raise an unspecified amount through this best efforts capital raise.
The takeaway
HeartSciences' securities offering represents an opportunity for investors to potentially gain a stake in a promising private medical technology firm focused on innovative cardiac monitoring solutions.
